“Cytomegalovirus Genetic Diversity Following Primary Infection.”, J Infect Dis, vol. 221, no. 5, pp. 715-720, 2020.
, “A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei.”, Vaccine, vol. 36, no. 32 Pt B, pp. 4880-4889, 2018.
, “Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.”, Lancet Infect Dis, vol. 17, no. 8, pp. 843-853, 2017.
, “Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules.”, Pediatrics, vol. 137, no. 2, p. e20152603, 2016.
, “Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults.”, Vaccine, vol. 33, no. 31, pp. 3766-72, 2015.
,